Treatment outcomes and key factors contributing to unfavourable outcomes among isoniazid-resistant pulmonary tuberculosis patients in Shanghai, China

Objective: Given that more than 1 million people annually develop isoniazid-resistant tuberculosis (Hr-TB), the issue of Hr-TB may go unnoticed. However, limited studies have focused on the clinical treatment of Hr-TB in China, particularly regarding treatment outcomes and influencing factors. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjing Xiao, Jing Chen, Lixin Rao, Xiao Xiao, Xubin Zheng, Zheyuan Wu, Xin Shen
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716525000372
Tags: Add Tag
No Tags, Be the first to tag this record!